STOCK TITAN

Horizon Technology Finance Corporation - $HRZN STOCK NEWS

Welcome to our dedicated page for Horizon Technology Finance Corporation news (Ticker: $HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Technology Finance Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Horizon Technology Finance Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Horizon Technology Finance Corporation's position in the market.

Rhea-AI Summary
Parse Biosciences (HRZN) secures $50 million in financing to expand single cell sequencing solutions and serve academic, biotech, and pharma customers. The funding, led by Soleus Capital, will drive the company's product portfolio and commercial reach, bringing total funding to over $100 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
Rhea-AI Summary
Horizon Technology Finance Corporation (NASDAQ: HRZN) has declared monthly cash distributions of $0.11 per share for January, February, and March 2024, as well as a special distribution of $0.05 per share for December 2023. Since its IPO in 2010, Horizon has paid a total of $237 million in distributions to shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.78%
Tags
none
-
Rhea-AI Summary
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced its financial results for Q3 2023. Net investment income per share was $0.53, NAV per share was $10.41. The debt portfolio yield was 17.1%. The portfolio grew by 15% YoY to $729 million. The Horizon Platform ended the quarter with a committed backlog of $222 million, including $202 million in HRZN commitments. Regular monthly distributions totaling $0.33 per share through March 2024 and a $0.05 special distribution payable in December 2023 were declared.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.78%
Tags
Rhea-AI Summary
Horizon Technology Finance Corporation plans to release financial results for Q3 2023 on October 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
The 26th BioFlorida Annual Conference highlighted the growth and success of Florida's life sciences industry. The conference featured discussions on various topics including medical innovations, advancements in neurodegeneration, and financing insights. BioFlorida also announced a strategic partnership with BIOQuébec. The conference recognized individuals and organizations for their achievements and presented awards in different categories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
none
-
Rhea-AI Summary
Horizon Technology Finance Provides Q3 2023 Portfolio Update
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
Rhea-AI Summary
Horizon Technology Finance Corporation provides $35 million venture loan facility to Mirantis, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
-
Rhea-AI Summary
Horizon Technology Finance provides $40 million venture loan facility to Elligo Health Research, Inc. to revolutionize clinical research with its innovative technology platform. The loan proceeds will be used for general growth and working capital purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
none
-
Rhea-AI Summary
Horizon Technology Finance Management LLC hires Paul A. D'Agrosa as Vice President, Business Development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
Rhea-AI Summary
Sonex Health closes Series B financing, raising $40 million to expand access to ultrasound-guided devices for treating carpal tunnel syndrome and trigger finger.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
none
Horizon Technology Finance Corporation

Nasdaq:HRZN

HRZN Rankings

HRZN Stock Data

413.60M
35.02M
1.32%
5.34%
1.68%
Securities and Commodity Exchanges
Finance and Insurance
Link
United States of America
FARMINGTON

About HRZN

horizon is a venture lending platform that thoughtfully and creatively provides structured debt products to life science and technology companies. horizon's experienced team of investment and operations professionals have been providing debt capital to some of the most exciting companies for decades. since 2004, horizon has directly originated and invested more than $1.2 billion in venture loans to more than 200 growing companies. with horizon's industry knowledge and proven reliability as a capital source, combined with its long-standing relationships in the venture capital community, the horizon team shares the optimism of its portfolio companies and their commitment to overcome any obstacles to success. horizon is opportunistic and forward-looking. taking the long view does more than bridge the financial gap. it allows horizon's portfolio companies to get from where they are to where they want to be. headquartered in farmington, connecticut, horizon technology finance corporation (n